Employee-related Liabilities, Current in USD of PROVECTUS BIOPHARMACEUTICALS, INC. from Q1 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Provectus Biopharmaceuticals, Inc. quarterly Employee-related Liabilities, Current history and change rate from Q1 2013 to Q3 2025.
  • Provectus Biopharmaceuticals, Inc. Employee-related Liabilities, Current for the quarter ending September 30, 2025 was $310K.
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $310K +$310K Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $233K -$1.82M -88.7% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $155K -$1.82M -92.2% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $77.5K -$2.25M -96.7% Dec 31, 2024 10-Q 2025-11-13
Q3 2024 $0 -$2.23M -100% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $2.05M -$83.8K -3.92% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.98M Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.33M +$385K +19.8% Dec 31, 2023 10-K 2025-03-28
Q3 2023 $2.23M Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.14M Jun 30, 2023 10-Q 2023-08-14
Q4 2022 $1.95M Dec 31, 2022 10-K 2024-03-28
Q3 2013 $98.7K Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $176K Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $79.6K Mar 31, 2013 10-Q 2013-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.